Towards Healthcare
Next-Generation AI in Life Sciences Market 2025 Drives Clinical and Model Bre...

Next-Generation AI in Life Sciences Market Led by North America with 50% Share in 2024

The next-generation AI in life sciences market is growing rapidly due to a growing focus on providing high-quality healthcare services in less time. North America’s dominance is attributed to the rising focus on evidence-based healthcare practices, which can be achieved in less time with generative AI.

  • Insight Code: 5814
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

Next-generation AI in life sciences market is set for strong growth from 2025 to 2034, driven by rising demand and tech advancements.

North America is currently leading the next-generation AI in life sciences market due to technological advancements, focus on developing advanced healthcare infrastructure, and contributions by leading market players.

The next-generation AI in life sciences market includes seven segments such as by application, by AI technology type, by deployment type, by end-user, by therapeutic area, by data source, and by region.

Some key players include NVIDIA (Clara, BioNeMo), Google DeepMind (AlphaFold, MedPaLM), Insilico Medicine, Recursion Pharmaceuticals, Exscientia, BenevolentAI, Owkin, Atomwise, PathAI, etc. 

Key trends include technological advancements, training AI models, and the development of new AI-based tools and equipment.

Manufacturers in the life sciences may save expenses, improve product quality, and shorten time to market with gen AI.

Businesses should think about using GenAI technologies to learn, extract value right away, and climb the ladder to more radical change.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.